Get Premium to unlock powerful stock data
NAS:JAZZ (Ireland)  
Jazz Pharmaceuticals PLC logo

Jazz Pharmaceuticals PLC

$ 156.01 -0.35 (-0.22%) 04:00 PM EST
On watch
P/E:
At Loss
P/B:
2.69
Market Cap:
$ 9.74B
Enterprise V:
$ 15.40B
Volume:
436.01K
Avg Vol (2M):
572.63K
Also Trade In:
Volume:
436.01K
Market Cap $:
9.74B
PE Ratio:
At Loss
Avg Vol (2-Month):
572.63K
Enterprise Value $:
15.40B
PB Ratio:
2.69
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Jazz Pharmaceuticals PLC
NAICS : 325412 SIC : 2834
Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, IRL, D04 E5W7
Description
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small-cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Name Current Vs Industry Vs History
Cash-To-Debt 0.08
Equity-to-Asset 0.31
Debt-to-Equity 1.7
Debt-to-EBITDA 8.29
Interest Coverage 0.3
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.31
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 73.91
9-Day RSI 65.01
14-Day RSI 59.23
6-1 Month Momentum % 14.73
12-1 Month Momentum % -15.71

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.39
Quick Ratio 2.06
Cash Ratio 0.67
Days Inventory 645.69
Days Sales Outstanding 56.52
Days Payable 53.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.3

Financials (Next Earnings Date:2022-08-03 Est.)

JAZZ's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:JAZZ

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 3,300.378
EPS (TTM) ($) -7.51
Beta 0.79
Volatility % 32.37
14-Day RSI 59.23
14-Day ATR ($) 4.596127
20-Day SMA ($) 149.3885
12-1 Month Momentum % -15.71
52-Week Range ($) 117.64 - 186.22
Shares Outstanding (Mil) 62.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Jazz Pharmaceuticals PLC Filings

Document Form Filing Date
No Filing Data

Headlines

See More